Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial - PubMed (original) (raw)
Clinical Trial
. 2003 Jul;14(7 Suppl 2):S108-13.
doi: 10.1097/01.asn.0000070157.96264.13.
Johan G Eriksson, Timo T Valle, Sirkka Aunola, Zygimantas Cepaitis, Martti Hakumäki, Helena Hämäläinen, Pirjo Ilanne-Parikka, Sirkka Keinänen-Kiukaanniemi, Mauri Laakso, Anne Louheranta, Marjo Mannelin, Vesa Martikkala, Vladislav Moltchanov, Merja Rastas, Virpi Salminen, Jouko Sundvall, Matti Uusitupa, Jaakko Tuomilehto
Affiliations
- PMID: 12819313
- DOI: 10.1097/01.asn.0000070157.96264.13
Clinical Trial
Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial
Jaana Lindström et al. J Am Soc Nephrol. 2003 Jul.
Abstract
Type 2 diabetes mellitus is increasing worldwide largely as a result from increasing obesity and sedentary lifestyle. The Finnish Diabetes Prevention Study (DPS) is the first individually randomized controlled clinical trial to test the feasibility and efficacy of lifestyle modification in high-risk subjects. We randomly assigned 522 (172 men, 350 women) middle-aged (mean age 55 yr), overweight (mean body mass index 31 kg/m(2)) subjects with impaired glucose tolerance either to the lifestyle intervention or control group. Each subject in the intervention group received individualized counseling aimed at reducing weight and intake of total and saturated fat, and increasing intake of fiber and physical activity. An oral glucose tolerance test was performed annually to detect incident cases of diabetes and to measure changes in metabolic parameters. The mean (+/- SD) weight reduction from baseline to year 1 and to year 2, respectively, was 4.2 +/- 5.1 kg and 3.5 +/- 5.5 in the intervention group and 0.8 +/- 3.7 kg and 0.8 +/- 4.4 in the control group (P < 0.001 between the groups). At the time of first analysis of the outcome data the mean duration of follow-up was 3.2 yr. The risk of diabetes was reduced by 58% (P < 0.001) in the intervention group compared with the control group. The reduction in the incidence of diabetes was directly associated with number and magnitude of lifestyle changes made. In conclusion, the DPS is the first controlled trial demonstrating that type 2 diabetes can be prevented by changes in lifestyle in high-risk subjects.
Similar articles
- Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group. Tuomilehto J, et al. N Engl J Med. 2001 May 3;344(18):1343-50. doi: 10.1056/NEJM200105033441801. N Engl J Med. 2001. PMID: 11333990 Clinical Trial. - How does lifestyle intervention affect depressive symptoms? Results from the Finnish Diabetes Prevention Study.
Ruusunen A, Voutilainen S, Karhunen L, Lehto SM, Tolmunen T, Keinänen-Kiukaanniemi S, Eriksson J, Tuomilehto J, Uusitupa M, Lindström J. Ruusunen A, et al. Diabet Med. 2012 Jul;29(7):e126-32. doi: 10.1111/j.1464-5491.2012.03602.x. Diabet Med. 2012. PMID: 22313027 Clinical Trial. - The Finnish Diabetes Prevention Study.
Uusitupa M, Louheranta A, Lindström J, Valle T, Sundvall J, Eriksson J, Tuomilehto J. Uusitupa M, et al. Br J Nutr. 2000 Mar;83 Suppl 1:S137-42. doi: 10.1017/s0007114500001070. Br J Nutr. 2000. PMID: 10889804 Clinical Trial. - Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].
Patnode CD, Evans CV, Senger CA, Redmond N, Lin JS. Patnode CD, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jul. Report No.: 15-05222-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jul. Report No.: 15-05222-EF-1. PMID: 29364620 Free Books & Documents. Review. - Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials.
Yoon U, Kwok LL, Magkidis A. Yoon U, et al. Metabolism. 2013 Feb;62(2):303-14. doi: 10.1016/j.metabol.2012.07.009. Epub 2012 Sep 7. Metabolism. 2013. PMID: 22959500 Review.
Cited by
- Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model-A multiregional case study.
Al-Omar HA, Czech M, Quang Nam T, Gottwald-Hostalek U, Vesic N, Whitehouse J, Dawson M. Al-Omar HA, et al. J Diabetes. 2024 May;16(5):e13553. doi: 10.1111/1753-0407.13553. J Diabetes. 2024. PMID: 38664882 Free PMC article. - Body weight changes and diabetes mellitus incident: A cohort study from the Middle East.
Salesi R, Kermani-Alghoraishi M, Sadeghi A, Roohafza H, Talaei M, Sarrafzadegan N, Sadeghi M. Salesi R, et al. J Prev Med Hyg. 2023 Nov 1;64(3):E345-E351. doi: 10.15167/2421-4248/jpmh2023.64.3.2650. eCollection 2023 Sep. J Prev Med Hyg. 2023. PMID: 38125999 Free PMC article. - Mobile Health Apps for the Control and Self-management of Type 2 Diabetes Mellitus: Qualitative Study on Users' Acceptability and Acceptance.
Bults M, van Leersum CM, Olthuis TJJ, Bekhuis REM, den Ouden MEM. Bults M, et al. JMIR Diabetes. 2023 Jan 24;8:e41076. doi: 10.2196/41076. JMIR Diabetes. 2023. PMID: 36692927 Free PMC article. - Population level impact of the NHS Diabetes Prevention Programme on incidence of type 2 diabetes in England: An observational study.
McManus E, Meacock R, Parkinson B, Sutton M. McManus E, et al. Lancet Reg Health Eur. 2022 May 29;19:100420. doi: 10.1016/j.lanepe.2022.100420. eCollection 2022 Aug. Lancet Reg Health Eur. 2022. PMID: 35664052 Free PMC article. - Effects of a 12-Month Hybrid (In-Person + Virtual) Education Program in the Glycemic Status of Arab Youth.
Al-Daghri NM, Amer OE, Hameidi A, Alfawaz H, Alharbi M, Khattak MNK, Alnaami AM, Aljohani NJ, Alkhaldi G, Wani K, Sabico S. Al-Daghri NM, et al. Nutrients. 2022 Apr 22;14(9):1759. doi: 10.3390/nu14091759. Nutrients. 2022. PMID: 35565727 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical